vs
Side-by-side financial comparison of Envela Corp (ELA) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
Envela Corp is the larger business by last-quarter revenue ($80.5M vs $47.7M, roughly 1.7× IRONWOOD PHARMACEUTICALS INC). Envela Corp runs the higher net margin — 7.4% vs -4.8%, a 12.2% gap on every dollar of revenue. On growth, Envela Corp posted the faster year-over-year revenue change (66.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-3.7M). Over the past eight quarters, Envela Corp's revenue compounded faster (42.1% CAGR vs -20.2%).
Envela Corporation is a U.S.-based company that provides recommerce services aimed at extending product lifecycles and reducing resource consumption. The company operates through two primary segments: consumer and commercial.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
ELA vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.5M | $47.7M |
| Net Profit | $6.0M | $-2.3M |
| Gross Margin | 20.5% | — |
| Operating Margin | 9.4% | 14.3% |
| Net Margin | 7.4% | -4.8% |
| Revenue YoY | 66.6% | -47.3% |
| Net Profit YoY | 274.6% | -200.9% |
| EPS (diluted) | $0.22 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $80.5M | $47.7M | ||
| Q3 25 | $57.4M | $122.1M | ||
| Q2 25 | $54.9M | $85.2M | ||
| Q1 25 | $48.3M | $41.1M | ||
| Q4 24 | $48.3M | $90.5M | ||
| Q3 24 | $46.9M | $91.6M | ||
| Q2 24 | $45.3M | $94.4M | ||
| Q1 24 | $39.9M | $74.9M |
| Q4 25 | $6.0M | $-2.3M | ||
| Q3 25 | $3.4M | $40.1M | ||
| Q2 25 | $2.8M | $23.6M | ||
| Q1 25 | $2.5M | $-37.4M | ||
| Q4 24 | $1.6M | $2.3M | ||
| Q3 24 | $1.7M | $3.6M | ||
| Q2 24 | $1.6M | $-860.0K | ||
| Q1 24 | $1.9M | $-4.2M |
| Q4 25 | 20.5% | — | ||
| Q3 25 | 22.8% | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 24.8% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | 24.4% | — | ||
| Q2 24 | 25.1% | — | ||
| Q1 24 | 25.9% | — |
| Q4 25 | 9.4% | 14.3% | ||
| Q3 25 | 7.3% | 61.8% | ||
| Q2 25 | 5.9% | 53.2% | ||
| Q1 25 | 6.5% | -70.7% | ||
| Q4 24 | 3.9% | 34.8% | ||
| Q3 24 | 4.3% | 28.0% | ||
| Q2 24 | 4.2% | 26.5% | ||
| Q1 24 | 5.9% | 14.7% |
| Q4 25 | 7.4% | -4.8% | ||
| Q3 25 | 5.8% | 32.8% | ||
| Q2 25 | 5.0% | 27.7% | ||
| Q1 25 | 5.2% | -90.9% | ||
| Q4 24 | 3.3% | 2.5% | ||
| Q3 24 | 3.6% | 4.0% | ||
| Q2 24 | 3.5% | -0.9% | ||
| Q1 24 | 4.8% | -5.6% |
| Q4 25 | $0.22 | $0.01 | ||
| Q3 25 | $0.13 | $0.23 | ||
| Q2 25 | $0.11 | $0.14 | ||
| Q1 25 | $0.10 | $-0.23 | ||
| Q4 24 | $0.07 | $0.03 | ||
| Q3 24 | $0.06 | $0.02 | ||
| Q2 24 | $0.06 | $-0.01 | ||
| Q1 24 | $0.07 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | $9.9M | — |
| Stockholders' EquityBook value | $67.1M | $-261.8M |
| Total Assets | $96.0M | $396.9M |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | $19.8M | $121.5M |
| Q4 25 | $9.9M | — | ||
| Q3 25 | $12.5M | $199.5M | ||
| Q2 25 | $13.0M | $199.3M | ||
| Q1 25 | $13.2M | $199.2M | ||
| Q4 24 | $13.5M | $199.0M | ||
| Q3 24 | $13.8M | $198.8M | ||
| Q2 24 | $14.3M | $198.6M | ||
| Q1 24 | $14.6M | $398.3M |
| Q4 25 | $67.1M | $-261.8M | ||
| Q3 25 | $61.1M | $-264.2M | ||
| Q2 25 | $57.8M | $-308.2M | ||
| Q1 25 | $55.1M | $-334.1M | ||
| Q4 24 | $52.7M | $-301.3M | ||
| Q3 24 | $51.1M | $-311.3M | ||
| Q2 24 | $50.2M | $-321.7M | ||
| Q1 24 | $49.3M | $-330.5M |
| Q4 25 | $96.0M | $396.9M | ||
| Q3 25 | $90.9M | $396.1M | ||
| Q2 25 | $82.7M | $342.9M | ||
| Q1 25 | $79.7M | $327.2M | ||
| Q4 24 | $77.9M | $350.9M | ||
| Q3 24 | $77.4M | $389.5M | ||
| Q2 24 | $73.8M | $395.6M | ||
| Q1 24 | $74.7M | $438.8M |
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.27× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | $74.6M |
| Free Cash FlowOCF − Capex | $-3.7M | $74.6M |
| FCF MarginFCF / Revenue | -4.6% | 156.3% |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.5M | $74.6M | ||
| Q3 25 | $2.4M | $47.6M | ||
| Q2 25 | $2.6M | $-15.1M | ||
| Q1 25 | $1.1M | $20.0M | ||
| Q4 24 | $3.7M | $15.2M | ||
| Q3 24 | $3.4M | $9.9M | ||
| Q2 24 | $-789.5K | $33.5M | ||
| Q1 24 | $3.8M | $45.0M |
| Q4 25 | $-3.7M | $74.6M | ||
| Q3 25 | $2.2M | $47.6M | ||
| Q2 25 | $2.1M | $-15.1M | ||
| Q1 25 | $746.6K | $19.9M | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $1.5M | $9.9M | ||
| Q2 24 | $-1.3M | $33.4M | ||
| Q1 24 | $3.3M | $44.9M |
| Q4 25 | -4.6% | 156.3% | ||
| Q3 25 | 3.8% | 39.0% | ||
| Q2 25 | 3.9% | -17.7% | ||
| Q1 25 | 1.5% | 48.4% | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 3.1% | 10.8% | ||
| Q2 24 | -2.9% | 35.4% | ||
| Q1 24 | 8.4% | 60.0% |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 1.0% | 0.0% | ||
| Q3 24 | 4.2% | 0.0% | ||
| Q2 24 | 1.1% | 0.1% | ||
| Q1 24 | 1.1% | 0.1% |
| Q4 25 | -0.59× | — | ||
| Q3 25 | 0.72× | 1.19× | ||
| Q2 25 | 0.94× | -0.64× | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 2.34× | 6.74× | ||
| Q3 24 | 2.05× | 2.71× | ||
| Q2 24 | -0.50× | — | ||
| Q1 24 | 1.99× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELA
| Consumer Segment | $67.7M | 84% |
| Commercial Segment | $12.8M | 16% |
IRWD
Segment breakdown not available.
